Recalcitrant granuloma faciale with 14-year follow-up
Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesiona...
Ausführliche Beschreibung
Autor*in: |
Keiko Shiba [verfasserIn] Reine Moriuchi [verfasserIn] Yusuke Morita [verfasserIn] Yohei Hamade [verfasserIn] Toshinari Miyauchi [verfasserIn] Kazuhiro Kikuchi [verfasserIn] Kikuo Tsuchiya [verfasserIn] Satoko Shimizu [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch ; Spanisch ; Französisch ; Polnisch |
Erschienen: |
2017 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Nasza Dermatologia Online - Our Dermatology Online, 2011, 8(2017), 2, Seite 183-185 |
---|---|
Übergeordnetes Werk: |
volume:8 ; year:2017 ; number:2 ; pages:183-185 |
Links: |
---|
DOI / URN: |
10.7241/ourd.20172.49 |
---|
Katalog-ID: |
DOAJ077642090 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ077642090 | ||
003 | DE-627 | ||
005 | 20230502151403.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7241/ourd.20172.49 |2 doi | |
035 | |a (DE-627)DOAJ077642090 | ||
035 | |a (DE-599)DOAJbfcd5985ce2a4d48a10afa24601bda04 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng |a spa |a fre |a pol | ||
050 | 0 | |a RL1-803 | |
100 | 0 | |a Keiko Shiba |e verfasserin |4 aut | |
245 | 1 | 0 | |a Recalcitrant granuloma faciale with 14-year follow-up |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF. | ||
650 | 4 | |a GF; Granuloma faciale; PSL | |
653 | 0 | |a Dermatology | |
700 | 0 | |a Reine Moriuchi |e verfasserin |4 aut | |
700 | 0 | |a Yusuke Morita |e verfasserin |4 aut | |
700 | 0 | |a Yohei Hamade |e verfasserin |4 aut | |
700 | 0 | |a Toshinari Miyauchi |e verfasserin |4 aut | |
700 | 0 | |a Kazuhiro Kikuchi |e verfasserin |4 aut | |
700 | 0 | |a Kikuo Tsuchiya |e verfasserin |4 aut | |
700 | 0 | |a Satoko Shimizu |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Nasza Dermatologia Online |d Our Dermatology Online, 2011 |g 8(2017), 2, Seite 183-185 |w (DE-627)1760606286 |x 20819390 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2017 |g number:2 |g pages:183-185 |
856 | 4 | 0 | |u https://doi.org/10.7241/ourd.20172.49 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/bfcd5985ce2a4d48a10afa24601bda04 |z kostenfrei |
856 | 4 | 0 | |u http://www.odermatol.com/issue-in-html/2017-2-14-granuloma/ |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2081-9390 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_4305 | ||
951 | |a AR | ||
952 | |d 8 |j 2017 |e 2 |h 183-185 |
author_variant |
k s ks r m rm y m ym y h yh t m tm k k kk k t kt s s ss |
---|---|
matchkey_str |
article:20819390:2017----::eactatrnlmfcaeih |
hierarchy_sort_str |
2017 |
callnumber-subject-code |
RL |
publishDate |
2017 |
allfields |
10.7241/ourd.20172.49 doi (DE-627)DOAJ077642090 (DE-599)DOAJbfcd5985ce2a4d48a10afa24601bda04 DE-627 ger DE-627 rakwb eng spa fre pol RL1-803 Keiko Shiba verfasserin aut Recalcitrant granuloma faciale with 14-year follow-up 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF. GF; Granuloma faciale; PSL Dermatology Reine Moriuchi verfasserin aut Yusuke Morita verfasserin aut Yohei Hamade verfasserin aut Toshinari Miyauchi verfasserin aut Kazuhiro Kikuchi verfasserin aut Kikuo Tsuchiya verfasserin aut Satoko Shimizu verfasserin aut In Nasza Dermatologia Online Our Dermatology Online, 2011 8(2017), 2, Seite 183-185 (DE-627)1760606286 20819390 nnns volume:8 year:2017 number:2 pages:183-185 https://doi.org/10.7241/ourd.20172.49 kostenfrei https://doaj.org/article/bfcd5985ce2a4d48a10afa24601bda04 kostenfrei http://www.odermatol.com/issue-in-html/2017-2-14-granuloma/ kostenfrei https://doaj.org/toc/2081-9390 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 8 2017 2 183-185 |
spelling |
10.7241/ourd.20172.49 doi (DE-627)DOAJ077642090 (DE-599)DOAJbfcd5985ce2a4d48a10afa24601bda04 DE-627 ger DE-627 rakwb eng spa fre pol RL1-803 Keiko Shiba verfasserin aut Recalcitrant granuloma faciale with 14-year follow-up 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF. GF; Granuloma faciale; PSL Dermatology Reine Moriuchi verfasserin aut Yusuke Morita verfasserin aut Yohei Hamade verfasserin aut Toshinari Miyauchi verfasserin aut Kazuhiro Kikuchi verfasserin aut Kikuo Tsuchiya verfasserin aut Satoko Shimizu verfasserin aut In Nasza Dermatologia Online Our Dermatology Online, 2011 8(2017), 2, Seite 183-185 (DE-627)1760606286 20819390 nnns volume:8 year:2017 number:2 pages:183-185 https://doi.org/10.7241/ourd.20172.49 kostenfrei https://doaj.org/article/bfcd5985ce2a4d48a10afa24601bda04 kostenfrei http://www.odermatol.com/issue-in-html/2017-2-14-granuloma/ kostenfrei https://doaj.org/toc/2081-9390 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 8 2017 2 183-185 |
allfields_unstemmed |
10.7241/ourd.20172.49 doi (DE-627)DOAJ077642090 (DE-599)DOAJbfcd5985ce2a4d48a10afa24601bda04 DE-627 ger DE-627 rakwb eng spa fre pol RL1-803 Keiko Shiba verfasserin aut Recalcitrant granuloma faciale with 14-year follow-up 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF. GF; Granuloma faciale; PSL Dermatology Reine Moriuchi verfasserin aut Yusuke Morita verfasserin aut Yohei Hamade verfasserin aut Toshinari Miyauchi verfasserin aut Kazuhiro Kikuchi verfasserin aut Kikuo Tsuchiya verfasserin aut Satoko Shimizu verfasserin aut In Nasza Dermatologia Online Our Dermatology Online, 2011 8(2017), 2, Seite 183-185 (DE-627)1760606286 20819390 nnns volume:8 year:2017 number:2 pages:183-185 https://doi.org/10.7241/ourd.20172.49 kostenfrei https://doaj.org/article/bfcd5985ce2a4d48a10afa24601bda04 kostenfrei http://www.odermatol.com/issue-in-html/2017-2-14-granuloma/ kostenfrei https://doaj.org/toc/2081-9390 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 8 2017 2 183-185 |
allfieldsGer |
10.7241/ourd.20172.49 doi (DE-627)DOAJ077642090 (DE-599)DOAJbfcd5985ce2a4d48a10afa24601bda04 DE-627 ger DE-627 rakwb eng spa fre pol RL1-803 Keiko Shiba verfasserin aut Recalcitrant granuloma faciale with 14-year follow-up 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF. GF; Granuloma faciale; PSL Dermatology Reine Moriuchi verfasserin aut Yusuke Morita verfasserin aut Yohei Hamade verfasserin aut Toshinari Miyauchi verfasserin aut Kazuhiro Kikuchi verfasserin aut Kikuo Tsuchiya verfasserin aut Satoko Shimizu verfasserin aut In Nasza Dermatologia Online Our Dermatology Online, 2011 8(2017), 2, Seite 183-185 (DE-627)1760606286 20819390 nnns volume:8 year:2017 number:2 pages:183-185 https://doi.org/10.7241/ourd.20172.49 kostenfrei https://doaj.org/article/bfcd5985ce2a4d48a10afa24601bda04 kostenfrei http://www.odermatol.com/issue-in-html/2017-2-14-granuloma/ kostenfrei https://doaj.org/toc/2081-9390 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 8 2017 2 183-185 |
allfieldsSound |
10.7241/ourd.20172.49 doi (DE-627)DOAJ077642090 (DE-599)DOAJbfcd5985ce2a4d48a10afa24601bda04 DE-627 ger DE-627 rakwb eng spa fre pol RL1-803 Keiko Shiba verfasserin aut Recalcitrant granuloma faciale with 14-year follow-up 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF. GF; Granuloma faciale; PSL Dermatology Reine Moriuchi verfasserin aut Yusuke Morita verfasserin aut Yohei Hamade verfasserin aut Toshinari Miyauchi verfasserin aut Kazuhiro Kikuchi verfasserin aut Kikuo Tsuchiya verfasserin aut Satoko Shimizu verfasserin aut In Nasza Dermatologia Online Our Dermatology Online, 2011 8(2017), 2, Seite 183-185 (DE-627)1760606286 20819390 nnns volume:8 year:2017 number:2 pages:183-185 https://doi.org/10.7241/ourd.20172.49 kostenfrei https://doaj.org/article/bfcd5985ce2a4d48a10afa24601bda04 kostenfrei http://www.odermatol.com/issue-in-html/2017-2-14-granuloma/ kostenfrei https://doaj.org/toc/2081-9390 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 8 2017 2 183-185 |
language |
English Spanish French Polish |
source |
In Nasza Dermatologia Online 8(2017), 2, Seite 183-185 volume:8 year:2017 number:2 pages:183-185 |
sourceStr |
In Nasza Dermatologia Online 8(2017), 2, Seite 183-185 volume:8 year:2017 number:2 pages:183-185 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
GF; Granuloma faciale; PSL Dermatology |
isfreeaccess_bool |
true |
container_title |
Nasza Dermatologia Online |
authorswithroles_txt_mv |
Keiko Shiba @@aut@@ Reine Moriuchi @@aut@@ Yusuke Morita @@aut@@ Yohei Hamade @@aut@@ Toshinari Miyauchi @@aut@@ Kazuhiro Kikuchi @@aut@@ Kikuo Tsuchiya @@aut@@ Satoko Shimizu @@aut@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
1760606286 |
id |
DOAJ077642090 |
language_de |
englisch spanisch franzoesisch polnisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ077642090</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502151403.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.7241/ourd.20172.49</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ077642090</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJbfcd5985ce2a4d48a10afa24601bda04</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">spa</subfield><subfield code="a">fre</subfield><subfield code="a">pol</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RL1-803</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Keiko Shiba</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Recalcitrant granuloma faciale with 14-year follow-up</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">GF; Granuloma faciale; PSL</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Dermatology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Reine Moriuchi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yusuke Morita</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yohei Hamade</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Toshinari Miyauchi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kazuhiro Kikuchi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kikuo Tsuchiya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Satoko Shimizu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Nasza Dermatologia Online</subfield><subfield code="d">Our Dermatology Online, 2011</subfield><subfield code="g">8(2017), 2, Seite 183-185</subfield><subfield code="w">(DE-627)1760606286</subfield><subfield code="x">20819390</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:8</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:183-185</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.7241/ourd.20172.49</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/bfcd5985ce2a4d48a10afa24601bda04</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.odermatol.com/issue-in-html/2017-2-14-granuloma/</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2081-9390</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">8</subfield><subfield code="j">2017</subfield><subfield code="e">2</subfield><subfield code="h">183-185</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Keiko Shiba |
spellingShingle |
Keiko Shiba misc RL1-803 misc GF; Granuloma faciale; PSL misc Dermatology Recalcitrant granuloma faciale with 14-year follow-up |
authorStr |
Keiko Shiba |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760606286 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RL1-803 |
illustrated |
Not Illustrated |
issn |
20819390 |
topic_title |
RL1-803 Recalcitrant granuloma faciale with 14-year follow-up GF; Granuloma faciale; PSL |
topic |
misc RL1-803 misc GF; Granuloma faciale; PSL misc Dermatology |
topic_unstemmed |
misc RL1-803 misc GF; Granuloma faciale; PSL misc Dermatology |
topic_browse |
misc RL1-803 misc GF; Granuloma faciale; PSL misc Dermatology |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Nasza Dermatologia Online |
hierarchy_parent_id |
1760606286 |
hierarchy_top_title |
Nasza Dermatologia Online |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1760606286 |
title |
Recalcitrant granuloma faciale with 14-year follow-up |
ctrlnum |
(DE-627)DOAJ077642090 (DE-599)DOAJbfcd5985ce2a4d48a10afa24601bda04 |
title_full |
Recalcitrant granuloma faciale with 14-year follow-up |
author_sort |
Keiko Shiba |
journal |
Nasza Dermatologia Online |
journalStr |
Nasza Dermatologia Online |
callnumber-first-code |
R |
lang_code |
eng spa fre pol |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
txt |
container_start_page |
183 |
author_browse |
Keiko Shiba Reine Moriuchi Yusuke Morita Yohei Hamade Toshinari Miyauchi Kazuhiro Kikuchi Kikuo Tsuchiya Satoko Shimizu |
container_volume |
8 |
class |
RL1-803 |
format_se |
Elektronische Aufsätze |
author-letter |
Keiko Shiba |
doi_str_mv |
10.7241/ourd.20172.49 |
author2-role |
verfasserin |
title_sort |
recalcitrant granuloma faciale with 14-year follow-up |
callnumber |
RL1-803 |
title_auth |
Recalcitrant granuloma faciale with 14-year follow-up |
abstract |
Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF. |
abstractGer |
Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF. |
abstract_unstemmed |
Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 |
container_issue |
2 |
title_short |
Recalcitrant granuloma faciale with 14-year follow-up |
url |
https://doi.org/10.7241/ourd.20172.49 https://doaj.org/article/bfcd5985ce2a4d48a10afa24601bda04 http://www.odermatol.com/issue-in-html/2017-2-14-granuloma/ https://doaj.org/toc/2081-9390 |
remote_bool |
true |
author2 |
Reine Moriuchi Yusuke Morita Yohei Hamade Toshinari Miyauchi Kazuhiro Kikuchi Kikuo Tsuchiya Satoko Shimizu |
author2Str |
Reine Moriuchi Yusuke Morita Yohei Hamade Toshinari Miyauchi Kazuhiro Kikuchi Kikuo Tsuchiya Satoko Shimizu |
ppnlink |
1760606286 |
callnumber-subject |
RL - Dermatology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.7241/ourd.20172.49 |
callnumber-a |
RL1-803 |
up_date |
2024-07-04T01:59:43.083Z |
_version_ |
1803611939101736960 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ077642090</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502151403.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.7241/ourd.20172.49</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ077642090</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJbfcd5985ce2a4d48a10afa24601bda04</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">spa</subfield><subfield code="a">fre</subfield><subfield code="a">pol</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RL1-803</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Keiko Shiba</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Recalcitrant granuloma faciale with 14-year follow-up</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Granuloma faciale (GF) is an uncommon inflammatory dermatosis that is characterized by one or several asymptomatic brown red nodules or plaques usually occurring on the face. GF is known to be extremely resistant to treatment. Various treatments have been attempted, including topical or intralesional or systemic corticosteroids, dapsone, antimalarials, colchicine, topical tacrolimus, and topical psoralen; however, none of these have been found to be reliably efficacious. We tried numerous combinations and rotations of therapeutic modalities for GF over a long time. We described a case of GF in which the eruptions were carefully observed over the course of 14 years before finally resolving. Our experience suggests that continuous and careful follow-up, and trials of combinations and rotations of therapeutic modalities are essential for treating GF.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">GF; Granuloma faciale; PSL</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Dermatology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Reine Moriuchi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yusuke Morita</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yohei Hamade</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Toshinari Miyauchi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kazuhiro Kikuchi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kikuo Tsuchiya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Satoko Shimizu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Nasza Dermatologia Online</subfield><subfield code="d">Our Dermatology Online, 2011</subfield><subfield code="g">8(2017), 2, Seite 183-185</subfield><subfield code="w">(DE-627)1760606286</subfield><subfield code="x">20819390</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:8</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:183-185</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.7241/ourd.20172.49</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/bfcd5985ce2a4d48a10afa24601bda04</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.odermatol.com/issue-in-html/2017-2-14-granuloma/</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2081-9390</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">8</subfield><subfield code="j">2017</subfield><subfield code="e">2</subfield><subfield code="h">183-185</subfield></datafield></record></collection>
|
score |
7.401144 |